Cargando…

In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer’s disease pathology

BACKGROUND: Alzheimer’s disease (AD) is characterized by the abnormal accumulation of extracellular beta-amyloid (Abeta) plaques, intracellular hyperphosphorylated tau, progressive synaptic alterations, axonal dystrophies, neuronal loss and the deterioration of cognitive capabilities of patients. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trujillo-Estrada, Laura, Jimenez, Sebastian, De Castro, Vanessa, Torres, Manuel, Baglietto-Vargas, David, Moreno-Gonzalez, Ines, Navarro, Victoria, Sanchez-Varo, Raquel, Sanchez-Mejias, Elisabeth, Davila, Jose Carlos, Vizuete, Marisa, Gutierrez, Antonia, Vitorica, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833287/ https://www.ncbi.nlm.nih.gov/pubmed/24252759 http://dx.doi.org/10.1186/2051-5960-1-73

Ejemplares similares

Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus
por: Torres, Manuel, et al.
Publicado: (2012)

Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis
por: Sanchez-Varo, Raquel, et al.
Publicado: (2021)

Dual roles of Aβ in proliferative processes in an amyloidogenic model of Alzheimer’s disease
por: Baglietto-Vargas, David, et al.
Publicado: (2017)

Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
por: Sanchez-Mejias, Elisabeth, et al.
Publicado: (2016)

Monocyte-derived cells invade brain parenchyma and amyloid plaques in human Alzheimer’s disease hippocampus
por: Muñoz-Castro, Clara, et al.
Publicado: (2023)

Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus
por: Sanchez-Varo, Raquel, et al.
Publicado: (2011)

Microglia in Alzheimer’s Disease: Activated, Dysfunctional or Degenerative
por: Navarro, Victoria, et al.
Publicado: (2018)

Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
por: Sanchez-Varo, Raquel, et al.
Publicado: (2022)

Distinct disease‐sensitive GABAergic neurons in the perirhinal cortex of Alzheimer's mice and patients
por: Sanchez‐Mejias, Elisabeth, et al.
Publicado: (2019)

Disruption of Amyloid Plaques Integrity Affects the Soluble Oligomers Content from Alzheimer Disease Brains
por: Jimenez, Sebastian, et al.
Publicado: (2014)

Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease
por: Gomez‐Arboledas, Angela, et al.
Publicado: (2017)

Enhancing microtubule stabilization rescues cognitive deficits and ameliorates pathological phenotype in an amyloidogenic Alzheimer’s disease model
por: Fernandez-Valenzuela, Juan Jose, et al.
Publicado: (2020)

Mannan-Abeta(28 )conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice
por: Petrushina, Irina, et al.
Publicado: (2008)

Distinct Microglial Responses in Two Transgenic Murine Models of TAU Pathology
por: Romero-Molina, Carmen, et al.
Publicado: (2018)

Editorial: Risk Factors for Alzheimer's Disease
por: Moreno-Gonzalez, Ines, et al.
Publicado: (2020)

Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer’s Disease
por: Garcia-Leon, Juan Antonio, et al.
Publicado: (2020)

Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review
por: Moreth, Jens, et al.
Publicado: (2013)

Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers
por: Chang, Han-Wen, et al.
Publicado: (2022)

Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X
por: Antonios, Gregory, et al.
Publicado: (2015)

Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease
por: Thijssen, Elisabeth H., et al.
Publicado: (2021)

Should We Open Fire on Microglia? Depletion Models as Tools to Elucidate Microglial Role in Health and Alzheimer’s Disease
por: Romero-Molina, Carmen, et al.
Publicado: (2021)

Potential sources of interference on Abeta immunoassays in biological samples
por: Vanderstichele, Hugo, et al.
Publicado: (2012)

Systemic Administration of Abeta mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse Model
por: Catchpole, Ian, et al.
Publicado: (2013)

Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies
por: Fuller, James P., et al.
Publicado: (2015)

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study
por: Bermejo-Pareja, Felix, et al.
Publicado: (2010)

A Chemical Analog of Curcumin as an Improved Inhibitor of Amyloid Abeta Oligomerization
por: Orlando, Robert A., et al.
Publicado: (2012)

Acute Blast Injury Reduces Brain Abeta in Two Rodent Species
por: De Gasperi, Rita, et al.
Publicado: (2012)

Melatonin and Abeta, Macular Degeneration and Alzheimers Disease: Same Disease, Different Outcomes?
por: Vladan, Bajic, et al.
Publicado: (2012)

Acute and Chronic Sustained Hypoxia Do Not Substantially Regulate Amyloid-β Peptide Generation In Vivo
por: Serrano-Pozo, Alberto, et al.
Publicado: (2017)

Endogenous mouse huntingtin is highly abundant in cranial nerve nuclei, co-aggregates to Abeta plaques and is induced in reactive astrocytes in a transgenic mouse model of Alzheimer’s disease
por: Hartlage-Rübsamen, Maike, et al.
Publicado: (2019)

Abeta42-Induced Neurodegeneration via an Age-Dependent Autophagic-Lysosomal Injury in Drosophila
por: Ling, Daijun, et al.
Publicado: (2009)

Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
por: Harach, T., et al.
Publicado: (2017)

Successful Nutritional Intervention for an Infant with Abetalipoproteinemia: A Novel Modular Formula (AbetaMF)
por: Ueda, Masako, et al.
Publicado: (2021)

Abeta is prerequisite, but insufficient to cause tau phosphorylation in vivo: tau phosphorylation in APP mice by diabetes
por: Sato, Naoyuki
Publicado: (2013)

Erratum: Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
por: Harach, T., et al.
Publicado: (2017)

Lithium not only stabilizes mood, it is also neuroprotective
por: Praharaj, Samir Kumar
Publicado: (2011)

The neuroprotective mechanism of lithium after ischaemic stroke
por: Chen, Beina, et al.
Publicado: (2022)

Effects of Different Force Fields and Temperatures on the Structural Character of Abeta (12–28) Peptide in Aqueous Solution
por: Cao, Zanxia, et al.
Publicado: (2011)

Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases
por: Wirths, Oliver, et al.
Publicado: (2009)

Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease
por: Bayer, Thomas A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5ooch176egpppvi57i8fq8jgpg